|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2008-9-22
|
|
pubmed:abstractText |
The purpose of this study was to explore the prevalence of disseminated tumor cells (DTCs) in bone marrow (BM) of clinically progression-free prostate cancer (PC) patients at least 2 years after curatively intended radiotherapy (RT) with or without adjuvant hormone treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1097-0045
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2008 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1607-14
|
|
pubmed:meshHeading |
pubmed-meshheading:18655095-Aged,
pubmed-meshheading:18655095-Bone Marrow,
pubmed-meshheading:18655095-Disease Progression,
pubmed-meshheading:18655095-Humans,
pubmed-meshheading:18655095-Immunohistochemistry,
pubmed-meshheading:18655095-Male,
pubmed-meshheading:18655095-Middle Aged,
pubmed-meshheading:18655095-Prognosis,
pubmed-meshheading:18655095-Prostatic Neoplasms,
pubmed-meshheading:18655095-Risk Assessment,
pubmed-meshheading:18655095-Staining and Labeling,
pubmed-meshheading:18655095-Time Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer.
|
|
pubmed:affiliation |
Norwegian Radium Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway. arne.berg@radiumhospitalet.no
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
